Skip to main content

Aebersold Sarah's Form 4 filing

Biolife Solutions Inc (BLFS) · filed Sep 18, 2024

Accession no.
0001628280-24-040831
Filed
Sep 18, 2024
Trade date
Jul 11-Sep 16, 2024
Filing delay
69 daysLate
Rule 10b5-1 plan
Checked

This filing lists 4 non-derivative transactions. Open-market sales total $17.5K. It was filed 69 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Aebersold SarahCIK 0001837756Officer (Chief Human Resources Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jul 11, 2024Common StockSSaleDisposed−187$20.54−$3,840.9861,496Direct
Jul 19, 2024Common StockSSaleDisposed−300$21.01−$6,30361,196Direct
Aug 21, 2024Common StockSSaleDisposed−64$25.61−$1,639.0461,132Direct
Sep 16, 2024Common StockSSaleDisposed−229$25.12−$5,752.4860,903Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)